Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry - Implications and Outlook - 2023 Edition

Summary. This report is the fourth edition of our analysis of mergers and acquisitions in the pharmaceutical contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

 | Source: ReportLinker ReportLinker

New York, July 21, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry - Implications and Outlook - 2023 Edition" - https://www.reportlinker.com/p06477420/?utm_source=GNW


Scope
This 59-page report gives important, expert insight you won’t find in any other source. 12 tables and 20 figures throughout the report illustrate major points and trends.

This report is required reading for -
- CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking
- Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence
- Private equity and stock analysts: target identification and analysis, portfolio company performance benchmarking

Reasons to Buy
- Overview of M&A in the Pharma CMO Industry
- Detailed view of CDMO performance by number of deals, based on Deals database
- Analysis of M&A and private equity investment by target’s specific manufacturing services
Read the full report: https://www.reportlinker.com/p06477420/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data

        


    
    

 
    



        

        
            GlobeNewswire